KT details some of the most dangerous household items and tactics you can use to improve your health without them. Plus, Kevin talks about his early career and takes your calls.
Time Magazine Reports Skin Cancer Is Up In Young People But Never Mention Sunscreen
What’s In Your Milk?
Cellphones, Cancer and Infertility
Roundup Herbicide Linked To Parkinson’s
The Many Health Benefits Of Raw Honey
Berries Enhance Brain Signaling
Detox Your Body With The Sun
The Correct, Easy Way To Make Smoothies For Better Health
Sunshine Helps Prevent Skin Cancer And Sunscreen Promotes It
Hungary Introduces Fat Tax On “Unhealthy” Foods
Antidepressants During Pregnancy Increases Heart Defects In Newborns
Take Trudeau on the Go! Click here to download this show to your iPod, mp3 player, or PC through iTunes!
Click below to watch the Kevin Trudeau Show!
January 23, 2012
By Andre Evans
A recent study has found that Monsanto’s Roundup pesticide may be responsible for causing infertility. After reviewing the many already well-documented negative impacts Roundup has on the environment and living creatures, it is no surprise to add yet another item to the list.
Researchers tested roundup on mature male rats at a concentration range between 1 and 10,000 parts per million (ppm), and found that within 1 to 48 hours of exposure, testicular cells of the mature rats were either damaged or killed. According to the study, even at a concentration of 1 ppm, the Roundup was able to affect the test subjects by decreasing their testosterone concentrations by as much as 35%.
How can such small levels of exposure have such a profound effect on the reproductive system? Roundup, being a glyphosate-based herbicide is also known to have endocrine disrupting properties.
Much like BPA, glyphosate-based herbicides have the ability to interfere with the natural hormonal balance in the human body, thereby introducing a number of health risks along with even the smallest levels of exposure. These chemicals are strong enough to affect your metabolism, behavior and mood, reproductive organs, and even provoke cancer.
As a result, any plants that are sprayed with roundup carry with them a chemical effect similar to that of other endocrine disruptors, offsetting the hormonal balance and causing adverse effects, despite even the smallest levels of exposure. This in part contributes to the number of males with increased fertility issues in more recent times.
January 16, 2012
By Mike Adams
The Dual Ridge Metal Boutique tissue boxes sold at Bed, Bath & Beyond stores have been discovered to be radioactive. Made with the extremely dangerous material used to blast cancer tumors with radiation — cobalt-60 — they emit gamma rays that are known to cause both cancer and infertility. They were manufactured in India, shipped on a commercial container to New Jersey, and then distributed to Bed, Bath & Beyond stores in 20 states.
How much radiation do these tissue holders emit, exactly? Nuclear Regulatory Commission spokesman David McIntyre said, on the record, that standing near one of these tissue holders for 30 minutes a day would expose you to the equivalent of “a couple of chest X-Rays” each year. The Illinois Emergency Management Agency went even further, issuing a release stating that every 10 hours spent near the product would expose you to the equivalent of one chest X-Ray.
In case you were wondering, a chest X-Ray is not a small dose of radiation.
Ever since Fukushima, the corporate-run media has downplayed the risks of radiation exposure, and now they’re claiming that these radioactive products are “no big deal” because they “only” expose you to the equivalent of multiple chest X-Rays each year.
What if a customer has this on their nightstand, near their head, and they’re sleeping next to it for 8 hours a night? That means they’d be getting nearly the equivalent radiation of a chest X-Ray each night for 365 nights a year!
October 28, 2011
By S. L. Baker
In vitro (which means “outside the body”) fertilization, better known as IVF, is the joining of a woman’s egg and a man’s sperm in a laboratory dish. The fertilized egg is placed in the lining of the woman’s womb and, if the fetus continues to grow, a baby is born in about 9 months. Although a huge money making part of the infertility industry, IVF has many downsides including the fact it is enormously expensive. A single IVF cycle treatment can cost over $12,000 and it can take many IVF treatments to achieve a pregnancy.
What’s more, the success rate after spending all this money is only about 13 to 43 percent, depending on the age of the would-be mother, with older moms having less chance of a successful pregnancy. On top of these drawbacks, the drugs given for ovarian stimulation have a host of side effects, according to the National Institutes of Health (NIH), including bloating, abdominal pain, mood swings and headaches.
Now there’s evidence of an even more potentially horrendous side effect to this baby making technology — ovarian cancer. Researchers from the Netherlands have discovered that women whose ovaries are stimulated into producing extra eggs for IVF double their risk of having ovarian malignancies later in life, compared to women who never undergo IVF. The study was just published in Europe’s leading reproductive medicine journal Human Reproduction.
The specific type of ovarian growths found that are most likely spurred by IVF are known as borderline ovarian tumors. While far less deadly than invasive ovarian malignancies, they are nothing that can be ignored. The researchers found that of the 25,152 women with fertility problems included in their study, 77 developed ovarian cancers. Surprisingly, of the 61 women who had ovarian malignancies in the group that had been treated with IVF, 31 had borderline ovarian cancer and 30 had invasive ovarian cancer.
Unusually high number of ovarian tumors in later years
In a statement to the media, lead researcher Professor Flora van Leeuwen, who heads the Department of Epidemiology in The Netherlands Cancer Institute in Amsterdam, noted this proportion of ovarian borderline tumors was unusually high. She warned that although borderline ovarian tumors have a low potential to be fatal, they “would require extensive surgery and cause substantial morbidity.”
Even after the research team adjusted for factors that could confound the results such as the age of the women, if they had already given birth and the cause of their fertility problems, the long-term risks for ovarian malignancies and borderline ovarian tumors were significantly higher in the IVF treatment group compared with the group of women not treated with IVF. For all ovarian malignancies and for borderline ovarian cancer, there was a two and four-fold higher risk, respectively, in the IVF treatment group. In addition, although not seen as “statistically significant,” the bottom line is that invasive ovarian cancer was also increased somewhat in the IVF treatment group.
“Our data clearly show that ovarian stimulation for IVF is associated with an increased risk of borderline ovarian tumors and this risk remains elevated up to more than 15 year after the first cycle of treatment,” Professor van Leeuwen said in the media statement.
October 6, 2011
USA Today Your Life
A drug that millions of pregnant women took decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other health problems that are showing up now, a new federal study finds.
Many of these daughters, now over 40, may not even know of their risk if their mothers never realized or told them they had used the drug, a synthetic estrogen called DES.
The new study suggests that infertility is twice as common and that breast cancer risk is nearly doubled in these daughters.
Debbie Wingard is one of them. The 59-year-old San Diego woman adopted two boys after being unable to conceive and has had breast cancer twice — when she was 39 and 49.
“There’s no knowing what’s going to happen as we age. There’s always the fear there’s going to be another cancer or another outcome,” she said. “I don’t think I’ll ever get to the point where I feel it’s behind me.”
The sons of DES users also face health risks — testicular problems and cysts — but these are less well studied and don’t seem to be as common. Even less is known about the third generation — “DES grandchildren.”
Some research suggests these girls start menstruating late and have irregular periods, possible signs of fertility issues down the road.
In the United States alone, more than 2 million women and 2 million men are thought to have been exposed to DES while in the womb and may now want to talk with their doctors about when they should be screened for health problems.
“We don’t want to cause a panic of everyone rushing out thinking they’re going to get cervical or breast cancer. They just need to have that conversation with their physician,” said Dr. Sharmila Makhija, women’s health chief at the University of Louisville.
The average woman has about a 1 in 50 chance of developing breast cancer by age 55; for DES daughters it’s 1 in 25, the study found. Risks for other health problems vary.
DES, or diethylstilbestrol, was widely used in the United States, Europe and elsewhere from the 1940s through the 1960s to prevent miscarriage, premature birth, bleeding and other problems. Many companies made and sold it as pills, creams and other forms.
Studies later showed it didn’t work. The government told doctors to stop using it in pregnancy in 1971, after DES daughters in their late teens and 20s were found to be at higher risk of a rare form of vaginal cancer. Further research has tied DES to infertility and various pregnancy problems.
“They’ve been identified one at a time. Nobody’s been able to get the whole picture,” said Dr. Robert Hoover, a researcher at the National Cancer Institute. The new study, which he led, “takes the woman and looks at everything that can happen as a result of this drug,” and adds evidence for some previously suspected risks like breast cancer, he said.
Results are in Thursday’s New England Journal of Medicine.
The study started in 1992 and involved about 4,600 DES daughters and a comparison group of 1,900 similar women whose mothers had not used DES. Their health was tracked over time through surveys and medical records. Their average age at the last followup was 48.
In the study, researchers found these rates of health problems in DES daughters compared to non-exposed women:
—Breast cancer, 3.9 percent versus 2.2 percent.
—Cervical pre-cancer, 6.9 percent versus 3.4 percent.
—Infertility, 33.3 percent versus 15.5 percent.
—Early menopause, 5.1 percent versus 1.7 percent
These complications were seen among women who were able to become pregnant:
—Preterm delivery, 53.3 percent versus 17.8 percent.
—Miscarriage, 50.3 percent versus 38.6 percent.
—Tubal pregnancy, 14.6 percent versus 2.9 percent.
—Stillbirth, 8.9 percent versus 2.6 percent.
—Preeclampsia (high blood pressure during pregnancy), 26.4 percent versus 13.7 percent.
The claim of added breast cancer risk is being tested by 53 women in a lawsuit against DES makers under way now in Boston. One of them is Jackie White, 48, who lives in Centerburg, Ohio, north of Columbus. She said she had a misshaped uterus and reproductive problems, and found a lump last year that turned out to be breast cancer. Tests showed 20 tumors in one breast, two pre-cancers in the other and spread to her lymph nodes.
“I ate a low-fat diet. I exercise faithfully so I was not overweight. I had none of the normal risk factors,” she said.
When and how often to screen women for breast cancer is the subject of much debate. A government task force recommends that women at average risk of breast cancer get mammograms every other year starting at age 50, and talk to their doctors about screening before then. Many medical groups urge starting at age 40.
DES exposure needs to be considered with the whole picture of a woman’s risk, said Dr. G. Wright Bates, director of reproductive medicine at the University of Alabama at Birmingham.
“In some cases, frequent Pap smears and early mammography or breast MRI may be warranted for women with DES exposure,” he said.
Others are focused on possible risks to the next generation.
Sally Keely, who was part of the federal study, and her husband are both offspring of women who took DES during pregnancy. Keely, 49, of Kalama, Wash., had miscarriages and a tubal pregnancy and required fertility treatments to have a daughter, now 9.
“I would like to push for more funding on the third generation exposed so I would know best how to advise my daughter,” she said.
Fran Howell, executive director of DES Action USA, an advocacy group based in Jupiter, Fla., adopted a daughter, now 20, after being unable to conceive.
“So many of the DES daughters worry about problems with their children,” she said. “The DES ends with me.”
Today, from a top secret location in Europe, Kevin explains how the cosmetics women wear these days are causing more damage than good. Plus, get the natural ways to cure annoying ailments, like allergies.
Take Trudeau on the Go! Click here to download this show to your iPod, mp3 player, or PC through iTunes!
Today, Kevin reveals the facts behind insider trading in Washington and how much your “representatives” are REALLY worth! Plus, the creator of the Resolve mineral detox, Dr. Ray Lala, stops by to explain how his mineral detox can virtually cure you from any viral infection, including herpes and HPV.
WH Staffer Calls Fox News’ Bret Baier A ‘Lunatic’
Congressional Trading on Advance Info Not Illegal
Congressional Staffers Gain From Trading in Stocks
Congress Mulls Trading Curbs for Its Own
Take Trudeau on the Go! Click here to download this show to your iPod, mp3 player, or PC through iTunes!
July 11, 2011
By Deirdre Imus
Let’s face it…we love our cell phones. Whether we use them for business or just to keep in touch with family and friends, for most of us, they have become indispensable. Nonetheless, there are new warnings about the health risks associated with cell phone use that consumers need to be aware of.
In May, after a thorough review of the existing research, the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), classified cell phones as “possibly carcinogenic to humans” and acknowledged that the radiation emitted from cell phones may increase an individual’s risk of brain cancer. Prior to this announcement, the WHO had maintained the position that no adverse health problems had been confirmed.
In one of the largest international studies undertaken, scientists found the rate of brain glioma (a type of tumor) doubled in individuals who used a cell phone for 10 years or more.
November 2nd, 2010
By: Martin Hickman
Some of the world’s biggest food companies are removing the chemical Bisphenol A from packaging, amid growing concern it is causing a wide range of human illnesses including heart disease and breast cancer.
Nestlé, the world’s biggest food manufacturer, says its will stop putting Bisphenol A (also known as BPA) into US products within three years, while tinned giant Heinz is at “an advanced stage” in removing it from UK baby food, and is funding research by one of the chemical’s leading critics. General Mills, the US giant behind the Green Giant tinned brand, has already ditched BPA from its Muir Glen tomato range, while Campbell Soups says it has done “hundreds” of tests exploring alternatives. Several other firms, such as Coca-Cola, have declined to disclose a timetable for its withdrawal, saying that BPA is safe.
BPA toughens the packaging of many tins, glass jars and plastic bottles, and the casings of electronics gadgets such as TVs, mobile phones and laptop computers.
Dozens of scientists say it is an endocrine disruptor that affects hormones and could be causing breast and prostate cancer, heart disease, brain retardation, impotence and infertility.
While the US says it has “some concern” about the chemical’s potential effects on the brain, on behaviour and on the prostate glands of foetuses, babies and young children, the European Food Safety Agency recent reiterated its view that the substance does not pose a risk to the public.
In a survey for a new report, Seeking Safer Packaging, the US investment fund Green Century Capital Management surveyed 26 food companies for their policy on BPA. Half said they were committed to ending use of the substance, double the 23 per cent found last year.
Emily Stone, of Green Century Capital Management, said: “Companies are actually moving faster than regulators in phasing out BPA from food and beverage packaging.” Some firms, such as Del Monte and Hain Celestial, have begun warning investors of a potential risk from tougher regulation of BPA use.
However it is possible that UK subsidiaries of some firms may take weaker action in Europe than in the US – where consumer awareness is much higher. While saying it was phasing out BPA in baby food, Nestlé told The Independent: “As a global food manufacturer and marketer, Nestlé takes into consideration local needs, cultural differences and consumer preferences as well as attitudes concerning the use of certain materials. This may well result in different solutions in various regions of the world…”
More than 20 US states have introduced legislation to restrict BPA use, Canada has listed it as a toxic chemical and several European countries have refused to accept the European Food Safety Agency’s latest position, released on 30 September.
Scientists are divided. While many endocrinologists, experts in hormones, believe low doses of BPA can harm humans, general toxicologists say evidence from large industry-funded studies suggests this is not the case.
Henrik Høegh, food minister in Denmark, which has has banned BPA in products for children up to three years old, said: “Our ban is based on a study which, according to Danish experts, shows uncertainty about the effects of even small doses of Bisphenol A on the learning ability in young rats.”
Where BPA is Used
* Tinned Food
BPA resin sprayed on the inside of tins prevents metal from contaminating food. The Independent found this year that BPA was present in 18 of the UK’s best-selling tins, including Heinz baked beans, Princes sardines, right, and Napolina tomatoes.
* Drinks cans
Some fizzy drinks, including Coca-Cola, are lined with a BPA resin. Pepsi has not said if its cans are lined with BPA.
* Glass jars
Some glass jars have BPA in the lid. Campaigners want firms such as Nestlé and Heinz to remove BPA from their baby and toddler food ranges because of fears over its impact on babies.
BPA is in the casings of electronics products including CDs, and DVDs, phones, TVs, laptops, personal computers, printers, cameras, shavers, hairdryers, irons, food mixers, microwaves and kettles.
* Plastic bottles
BPA is found in polycarbonate bottles designed to carry water or baby milk. Several manufacturers such as Tommee Tippee have phased out BPA.
* Sports equipment
Sports helmets, ski goggles, binocular housings and golf and tennis equipment contain the chemical.
* Till receipts
BPA is used to make ink visible on thermal till receipts. Concern arises about shoppers handling the paper and then touching their mouths or food.
* Medical equipment
BPA is found in the casings of dialysis machines, dentists’ operating lamps and blood sample reservoirs. It also toughens the lenses of spectacles.
“Heinz remains committed to moving to alternatives. Our plastic Heinz Beanz Snap Pots and Heinz Beanz Fridge Pack contain no BPA. All Heinz plastic baby food and juice containers, as well as packaging for our snacks and cereals, are BPA-free.
“Our baby food cans also contain no BPA and we are already at an advanced stage of phasing out the minute amounts of BPA used in the lids of jarred baby foods to ensure seal integrity, even though the BPA is coated and does not come into direct contact with the food at any time.
“Heinz continues to advance research into alternative coatings in response to consumer opinion but safety remains our first priority before making any changes.”
…and sticking with it
“The consensus repeatedly stated among regulatory agencies is that current levels of exposure to BPA through food and beverage packaging do not pose a health risk to the general population. BPA is found in the linings of our aluminium cans. Our bottled water and plastic soft drink containers are made from polyethylene terephthalate (PET) plastic, which does not contain BPA.
“While we are confident about the safety of our aluminium cans, we are always looking for ways to improve our packaging. We are working closely with several suppliers who are seeking alternatives. Any new material … also would have to meet our safety, quality and functional requirements.”
October 22nd, 2010
By: Ethan A. Huff
New research out of the University of Washington (UW) has some astounding new propositions for the use of Viagra, an erectile dysfunction drug made by Pfizer Inc. According to the report, young boys with Duchenne muscular dystrophy (DMD) can benefit from taking the drug because it allegedly treats the heart problems that typically emerge as a result of the disease.
Eager to expand the scope of Viagra’s prescribed uses, some researchers are now claiming that the drug helps to treat all sorts of diseases, even though it is linked to hearing loss, infertility, and nerve damage, among other things. But none of this has stopped co-authors Stanley Froehner, a professor of physiology and biophysics at UW, and Joseph Beavo, a professor of pharmacology at UW, from suggesting that Viagra now be used on adolescent boys.
DMD is a severe degenerative disease that eats away at spinal muscles, confining people who have it to wheelchairs by the time they are roughly ten years old. DMD can eventually cause heart failure as well, which is what the study authors claim Viagra will help prevent. But such a proposition is not only irresponsible based on the drug’s many side effects, but insane when considering the repercussions.
Froehner and Beavo have even suggested that young boys between the ages of eight and twelve be given Viagra as a preventive measure, before they even show any signs of heart problems. And they say that the dosage amounts for such purposes will most likely be higher than those given to older men to treat erectile dysfunction.